ralloc ado version 3 2 5 (STATA Corporation)
STATA Corporation is a verified supplier 
99
Structured Review
STATA Corporation
ralloc ado version 3 2 5
Ralloc Ado Version 3 2 5, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 4387 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ralloc+ado+version+3+2+5/STATA+3%2E0/10__1002_slash_14651858__cd012178__pub2-1139-7-11
Average 99 stars, based on 4387 article reviews
Ralloc Ado Version 3 2 5, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 4387 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ralloc+ado+version+3+2+5/STATA+3%2E0/10__1002_slash_14651858__cd012178__pub2-1139-7-11
Average 99 stars, based on 4387 article reviews
ralloc ado version 3 2 5 - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
Sequencing:Article Title: Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial Article Snippet: Paolo Manzoni a,*, Michael Meyer b, Ilaria Stolfi c, Matteo Rinaldi d, Silvia Cattani e, Lorenza Pugni f, Mario Giovanni Romeog, Hubert Messner h, Lidia Decembrino i, Nicola Laforgia j, Federica Vagnarelli k, Luigi Memo l, Linda Bordignon l, Milena Maulem, Elena Gallo a, Michael Mostert n, Michele Quercia j, Lina Bollani i, Roberto Pedicino c, Livia Renzullo h, Pasqua Betta g, Fabrizio Ferrari e, Tanith Alexander b, Rosario Magaldi d, Daniele Farina a, Fabio Mosca f, Mauro Stronati i Article Title: Nasal high-frequency oscillatory ventilation and CO 2 removal: A randomized controlled crossover trial. Article Snippet: Roberto Bottino MD | Federica Pontiggia MD | Cinzia Ricci MD | Alessandro Gambacorta MD | Angela Paladini MD | Vladimiras Chijenas MD | Arunas Liubsys MD | Jurate Navikiene MD | Ausrine Pliauckiene MD | Domenica Mercadante MD | Mariarosa Colnaghi MD | Milena Tana MD | Chiara Tirone MD | Alessandra Lio MD | Claudia Aurilia MD | Roberta Pastorino MD | Velia Purcaro MD | Gianfranco Maffei MD | Pio Liberatore MD | Chiara Consigli MD | Cristina Haass MD | Gianluca Lista MD | Massimo Agosti MD | Fabio Mosca MD | Giovanni Vento MD Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants. Article Snippet: Evid.-Based Child Health 9:3: 584–671 (2014) Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants Article Snippet: Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). Article Title: Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants Article Snippet: Background Lutein and zeaxanthin are nutrients with antioxidant properties found in the macula of the eye and brain tissue.. They have been reported to play a role in reducing oxidative damage, especially in the eyes and possibly in other organ systems.. Oxygen free radicals are one of the agents postulated to cause tissue damage in preterm infants, which leads to morbidities such as retinopathy of prematurity (ROP), intraventricular haemorrhage (IVH), and necrotising enterocolitis (NEC). Article Title: Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial. Article Snippet: .. The random allocation sequence was generated using Generated:Article Title: Bovine lactoferrin supplementation for prevention of necrotizing enterocolitis in very-low-birth-weight neonates: a randomized clinical trial Article Snippet: Paolo Manzoni a,*, Michael Meyer b, Ilaria Stolfi c, Matteo Rinaldi d, Silvia Cattani e, Lorenza Pugni f, Mario Giovanni Romeog, Hubert Messner h, Lidia Decembrino i, Nicola Laforgia j, Federica Vagnarelli k, Luigi Memo l, Linda Bordignon l, Milena Maulem, Elena Gallo a, Michael Mostert n, Michele Quercia j, Lina Bollani i, Roberto Pedicino c, Livia Renzullo h, Pasqua Betta g, Fabrizio Ferrari e, Tanith Alexander b, Rosario Magaldi d, Daniele Farina a, Fabio Mosca f, Mauro Stronati i Article Title: Nasal high-frequency oscillatory ventilation and CO 2 removal: A randomized controlled crossover trial. Article Snippet: Roberto Bottino MD | Federica Pontiggia MD | Cinzia Ricci MD | Alessandro Gambacorta MD | Angela Paladini MD | Vladimiras Chijenas MD | Arunas Liubsys MD | Jurate Navikiene MD | Ausrine Pliauckiene MD | Domenica Mercadante MD | Mariarosa Colnaghi MD | Milena Tana MD | Chiara Tirone MD | Alessandra Lio MD | Claudia Aurilia MD | Roberta Pastorino MD | Velia Purcaro MD | Gianfranco Maffei MD | Pio Liberatore MD | Chiara Consigli MD | Cristina Haass MD | Gianluca Lista MD | Massimo Agosti MD | Fabio Mosca MD | Giovanni Vento MD Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants. Article Snippet: Evid.-Based Child Health 9:3: 584–671 (2014) Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants Article Snippet: Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). Article Title: Lutein and zeaxanthin for reducing morbidity and mortality in preterm infants Article Snippet: Background Lutein and zeaxanthin are nutrients with antioxidant properties found in the macula of the eye and brain tissue.. They have been reported to play a role in reducing oxidative damage, especially in the eyes and possibly in other organ systems.. Oxygen free radicals are one of the agents postulated to cause tissue damage in preterm infants, which leads to morbidities such as retinopathy of prematurity (ROP), intraventricular haemorrhage (IVH), and necrotising enterocolitis (NEC). Article Title: Lutein and zeaxanthin supplementation in preterm very low-birth-weight neonates in neonatal intensive care units: a multicenter randomized controlled trial. Article Snippet: .. The random allocation sequence was generated using Selection:Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants. Article Snippet: Evid.-Based Child Health 9:3: 584–671 (2014) Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants Article Snippet: Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). Probiotics:Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants. Article Snippet: Evid.-Based Child Health 9:3: 584–671 (2014) Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants Article Snippet: Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). Control:Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants. Article Snippet: Evid.-Based Child Health 9:3: 584–671 (2014) Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants Article Snippet: Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). Infection:Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants. Article Snippet: Evid.-Based Child Health 9:3: 584–671 (2014) Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). Article Title: Probiotics for prevention of necrotizing enterocolitis in preterm infants Article Snippet: Main results Twenty-four eligible trials were included.. Included trials were highly variable with regard to enrolment criteria (that is birth weight and gestational age), baseline risk of NEC in the control groups, timing, dose, formulation of the probiotics, and feeding regimens.. In a meta-analysis of trial data, enteral probiotics supplementation significantly reduced the incidence of severe NEC (stage II or more) (typical relative risk (RR) 0.43, 95% confidence interval (CI) 0.33 to 0.56; 20 studies, 5529 infants) and mortality (typical RR 0.65, 95% CI 0.52 to 0.81; 17 studies, 5112 infants). |